Relationship between type 2 diabetes mellitus and markers of cutaneous melanoma aggressiveness: An observational multi-centric study in 443 patients with melanoma.

CONCLUSIONS: T2DM, rather than glycaemic control and metformin treatment, is associated with increased cutaneous melanoma aggressiveness at diagnosis. PMID: 33453061 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33453061?dopt=Abstract

Source: The British Journal of Dermatology - January 16, 2021 Category: Dermatology Authors: Nagore E, Martinez-Garcia MA, Gomez-Olivas JD, Manrique-Silva E, Martorell A, Bañuls J, Carrera C, Ortiz P, Gardeazabal J, Boada A, de Eusebio E, Chiner E, Gonzalez C, Pérez-Gil A, Cullen D, Formigón M, de Unamuno B, Navarro-Soriano C, Muriel A, Gozal Tags: Br J Dermatol Source Type: research